Hybrid Closed Loop Insulin Pump and Bariatric Surgery in Patients with Type 1 Diabetes

Launched by CENTRE HOSPITALIER SUD FRANCILIEN · Feb 28, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the safety and effectiveness of a hybrid closed-loop insulin pump for patients with type 1 diabetes who have also undergone bariatric surgery, which is a type of weight-loss surgery. Bariatric surgery can lead to both low blood sugar (hypoglycemia) and high blood sugar (hyperglycemia) episodes, and this study aims to better understand how the insulin pump can help manage these risks long-term in this specific group of patients.

To participate in the trial, you need to be between 65 and 74 years old, have been diagnosed with type 1 diabetes for more than a year, and be classified as obese (with a body mass index, or BMI, of 30 or higher). You should also have had bariatric surgery and currently be using a hybrid closed-loop insulin pump. It's important that you have not stopped using the insulin pump for more than 45 days after your surgery. If you choose to participate, you'll help researchers learn more about managing diabetes in patients who have had weight-loss surgery, which could lead to improved care for many people.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Major patient
• • With type 1 diabetes for \> 1 year
• • Obese (BMI≥30)
• • Having undergone bariatric surgery
• • On a hybrid closed-loop insulin pump
• • Not pregnant
• • No hybrid closed-loop insulin pump discontinuation for more than 45 days after surgery
• Exclusion Criteria:
• • - Patient informed and opposed to data use